GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
SG&A Expense Growth
3.92%
Quarterly · Period ending:
GSK SG&A Expense Growth
Latest reported3.92%period ending
Latest reported3.92%period ending
GSK Quarterly SG&A Growth (QoQ) (0.00% → 3.92%)
Latest values, visible window
High-resolution chart · PNG
GSK sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 3.9169% | |
| -19.7044% | |
| 17.8651% | |
| 4.6262% | |
| 3.3816% | |
| -22.2681% | |
| -29.9211% | |
| 54.1582% | |
| 18.1121% | |
| -22.0687% | |
| 16.6376% | |
| 1.2346% | |
| 5.8329% | |
| -12.1001% | |
| 18.5798% | |
| -0.484% | |
| 14.0177% | |
| -44.4172% | |
| 94.1632% | |
| -0.5921% | |
| -30.4079% | |
| -23.2448% | |
| 18.4713% | |
| -1.4766% | |
| -7.0988% | |
| -15.3064% | |
| 19.0526% | |
| 11.6602% | |
| 4.562% | |
| -5.458% | |
| 3.6803% | |
| 2.849% | |
| 6.3176% | |
| -8.7643% | |
| 9.7487% | |
| -2.9844% | |
| -2.9772% | |
| -9.5537% | |
| 18.281% | |
| 5.4278% | |
| -0.6852% | |
| -12.3699% | |
| 26.9309% | |
| -22.5502% | |
| 14.2022% | |
| 0.8156% | |
| 9.6374% | |
| -2.0438% | |
| 4.2618% | |
| -10.4091% | |
| 10.8871% | |
| -10.4693% | |
| 6.5385% | |
| -5.3685% | |
| -1.6995% | |
| 1.6364% | |
| 2.7077% | |
| -3.7736% | |
| 10.5812% | |
| -10.3341% | |
| 7.9327% | |
| -53.3737% | |
| 118.6765% | |
| -51.4517% | |
| 78.8085% | |
| -20.4469% | |
| 37.6514% | |
| -6.37% | |
| 4.1818% | |
| -4.1812% | |
| 26.2232% | |
| 1.2806% | |
| 2.9226% | |
| 3.1013% | |
| 4.7025% | |
| -12.1947% | |
| 10.0418% | |
| -13.4044% | |
| 19.4785% | |
| -14.165% | |
| 3.454% | |
| -10.6601% | |
| 8.1862% | |
| 12.2345% | |
| 2.0443% | |
| -13.4962% | |
| 15.3463% | |
| -7.5353% | |
| 3.3623% | |
| -13.2381% | |
| 1.8545% | |
| 6.3169% | |
| 2.2865% | |
| 0% | |
| -100% | |
| -7.0005% | |
| 9.009% | |
| 59.8752% | |
| -44.561% | |
| 3.0993% |